Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Price to Sales (2024 - 2026)

Updated

Rallybio's (RLYB) Price to Sales was 211.36 for Q3 2026, up 581.1% from 31.03 a year earlier and up 60.8% from the prior quarter.

Analysis

Rallybio (RLYB) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Rallybio was 33.81, down 46.0% from FY2024.

  • By year, Price to Sales came in at 62.66 in FY2024.
  • The Q3 2026 figure ranks as the highest quarterly Price to Sales in data going back to Q2 2024.
  • Year over year, Price to Sales has now increased in each of the last three quarters, with growth averaging 177.7% over the last six quarters.
  • Per Business Quant data, the three quarters before Q3 2026 came in at 131.44 (Q2 2026), 55.31 (Q1 2026) and 33.81 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rallybio 84.05 Mn -201.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 211.36
Jun 30, 2026 131.44
Mar 31, 2026 55.31
Dec 31, 2025 33.81
Sep 30, 2025 31.03
Jun 30, 2025 18.50
Mar 31, 2025 32.14
Dec 31, 2024 62.66
Sep 30, 2024 81.17
Jun 30, 2024 185.93
API Access

Rallybio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=RLYB&period=max&api_key=YOUR_API_KEY